271 related articles for article (PubMed ID: 38445632)
21. Multiple primary tumors following stage II and III rectal cancer in patients receiving radiotherapy, 1998-2010.
Smith-Gagen J; Goodwin GA; Tay J
J Cancer Res Clin Oncol; 2014 Jun; 140(6):949-55. PubMed ID: 24663823
[TBL] [Abstract][Full Text] [Related]
22. Phosphatidylinositol 3-kinase CB association with preoperative radiotherapy response in rectal adenocarcinoma.
Yu WD; Peng YF; Pan HD; Wang L; Li K; Gu J
World J Gastroenterol; 2014 Nov; 20(43):16258-67. PubMed ID: 25473181
[TBL] [Abstract][Full Text] [Related]
23. Short-course radiation followed by mFOLFOX-6 plus avelumab for locally-advanced rectal adenocarcinoma.
Shamseddine A; Zeidan YH; Kreidieh M; Khalifeh I; Turfa R; Kattan J; Mukherji D; Temraz S; Alqasem K; Amarin R; Al Awabdeh T; Deeba S; Jamali F; Mohamad I; Elkhaldi M; Daoud F; Al Masri M; Dabous A; Hushki A; Jaber O; Khoury C; El Husseini Z; Charafeddine M; Al Darazi M; Geara F
BMC Cancer; 2020 Sep; 20(1):831. PubMed ID: 32873251
[TBL] [Abstract][Full Text] [Related]
24. The Role of Canonical Wnt Signaling in Regulating Radioresistance.
Zhao Y; Tao L; Yi J; Song H; Chen L
Cell Physiol Biochem; 2018; 48(2):419-432. PubMed ID: 30021193
[TBL] [Abstract][Full Text] [Related]
25. Exosomes in Cancer Radioresistance.
Ni J; Bucci J; Malouf D; Knox M; Graham P; Li Y
Front Oncol; 2019; 9():869. PubMed ID: 31555599
[TBL] [Abstract][Full Text] [Related]
26. High dose rate brachytherapy as a boost after preoperative chemoradiotherapy for more advanced rectal tumours: the Clatterbridge experience.
Sun Myint A; Lee CD; Snee AJ; Perkins K; Jelley FE; Wong H
Clin Oncol (R Coll Radiol); 2007 Nov; 19(9):711-9. PubMed ID: 17884396
[TBL] [Abstract][Full Text] [Related]
27. Combination of radiotherapy and suppression of Tregs enhances abscopal antitumor effect and inhibits metastasis in rectal cancer.
Ji D; Song C; Li Y; Xia J; Wu Y; Jia J; Cui X; Yu S; Gu J
J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33106387
[TBL] [Abstract][Full Text] [Related]
28. Radiation-responsive scintillating nanotheranostics for reduced hypoxic radioresistance under ROS/NO-mediated tumor microenvironment regulation.
Dou Y; Liu Y; Zhao F; Guo Y; Li X; Wu M; Chang J; Yu C
Theranostics; 2018; 8(21):5870-5889. PubMed ID: 30613268
[TBL] [Abstract][Full Text] [Related]
29. PRDM15 interacts with DNA-PK-Ku complex to promote radioresistance in rectal cancer by facilitating DNA damage repair.
Yu Y; Liu T; Yu G; Wang H; Du Z; Chen Y; Yang N; Cao K; Liu C; Wan Z; Shen H; Gao F; Yang Y; Zhang W
Cell Death Dis; 2022 Nov; 13(11):978. PubMed ID: 36402747
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-130a modulates a radiosensitivity of rectal cancer by targeting SOX4.
Ha Thi HT; Kim HY; Kim YM; Hong S
Neoplasia; 2019 Sep; 21(9):882-892. PubMed ID: 31387015
[TBL] [Abstract][Full Text] [Related]
31. Role of Natural Radiosensitizers and Cancer Cell Radioresistance: An Update.
Malik A; Sultana M; Qazi A; Qazi MH; Parveen G; Waquar S; Ashraf AB; Rasool M
Anal Cell Pathol (Amst); 2016; 2016():6146595. PubMed ID: 26998418
[TBL] [Abstract][Full Text] [Related]
32. Short-course radiotherapy promotes pro-inflammatory macrophages via extracellular vesicles in human rectal cancer.
Stary V; Wolf B; Unterleuthner D; List J; Talic M; Laengle J; Beer A; Strobl J; Stary G; Dolznig H; Bergmann M
J Immunother Cancer; 2020 Aug; 8(2):. PubMed ID: 32817359
[TBL] [Abstract][Full Text] [Related]
33. CAF-secreted CXCL1 conferred radioresistance by regulating DNA damage response in a ROS-dependent manner in esophageal squamous cell carcinoma.
Zhang H; Yue J; Jiang Z; Zhou R; Xie R; Xu Y; Wu S
Cell Death Dis; 2017 May; 8(5):e2790. PubMed ID: 28518141
[TBL] [Abstract][Full Text] [Related]
34. Acquired radioresistance in cancer associated fibroblasts is concomitant with enhanced antioxidant potential and DNA repair capacity.
Domogauer JD; de Toledo SM; Howell RW; Azzam EI
Cell Commun Signal; 2021 Feb; 19(1):30. PubMed ID: 33637118
[TBL] [Abstract][Full Text] [Related]
35. Rab5C enhances resistance to ionizing radiation in rectal cancer.
Baptistella AR; Landemberger MC; Dias MVS; Giudice FS; Rodrigues BR; da Silva PPCE; Cassinela EK; Lacerda TC; Marchi FA; Leme AFP; Begnami MD; Aguiar S; Martins VR
J Mol Med (Berl); 2019 Jun; 97(6):855-869. PubMed ID: 30968159
[TBL] [Abstract][Full Text] [Related]
36. Regulatory network of competitively interacting RNAs and effectiveness of rectal tumors radiotherapy.
Kutilin DS; Gusareva MA; Kosheleva NG; Kit OI
Klin Onkol; 2022; 35(4):297-306. PubMed ID: 35989087
[TBL] [Abstract][Full Text] [Related]
37. Radiation-induced tumor immune microenvironments and potential targets for combination therapy.
Guo S; Yao Y; Tang Y; Xin Z; Wu D; Ni C; Huang J; Wei Q; Zhang T
Signal Transduct Target Ther; 2023 May; 8(1):205. PubMed ID: 37208386
[TBL] [Abstract][Full Text] [Related]
38. Exosomal miR-196a-5p enhances radioresistance in lung cancer cells by downregulating NFKBIA.
Yao F; Shi W; Fang F; Lv MY; Xu M; Wu SY; Huang CL
Kaohsiung J Med Sci; 2023 Jun; 39(6):554-564. PubMed ID: 36912495
[TBL] [Abstract][Full Text] [Related]
39. Exosomal miR-590-3p derived from cancer-associated fibroblasts confers radioresistance in colorectal cancer.
Chen X; Liu Y; Zhang Q; Liu B; Cheng Y; Zhang Y; Sun Y; Liu J
Mol Ther Nucleic Acids; 2021 Jun; 24():113-126. PubMed ID: 33738143
[TBL] [Abstract][Full Text] [Related]
40. Biological Adaptations of Tumor Cells to Radiation Therapy.
Carlos-Reyes A; Muñiz-Lino MA; Romero-Garcia S; López-Camarillo C; Hernández-de la Cruz ON
Front Oncol; 2021; 11():718636. PubMed ID: 34900673
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
